AAAAAA
Results:
1-7
|
Results: 7
Authors:
Blijlevens, NMA
Donnelly, JP
de Pauw, BE
Citation: Nma. Blijlevens et al., Empirical therapy of febrile neutropenic patients with mucositis: challenge of risk-based therapy, CL MICRO IN, 7, 2001, pp. 47-52
Authors:
Rex, JH
Walsh, TJ
Nettleman, M
Anaissie, EJ
Bennett, JE
Bow, EJ
Carillo-Munoz, AJ
Chavanet, P
Cloud, GA
Denning, DW
de Pauw, BE
Edwards, JE
Hiemenz, JW
Kauffman, CA
Lopez-Berestein, G
Martino, P
Sobel, JD
Stevens, DA
Sylvester, R
Tollemar, J
Viscoli, C
Viviani, MA
Wu, T
Citation: Jh. Rex et al., Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses, CLIN INF D, 33(1), 2001, pp. 95-106
Authors:
Ascioglu, S
de Pauw, BE
Meis, JFGM
Citation: S. Ascioglu et al., Prophylaxis and treatment of fungal infections associated with haematological malignancies, INT J ANT A, 15(3), 2000, pp. 159-168
Authors:
Voss, A
de Pauw, BE
Citation: A. Voss et Be. De Pauw, High-dose fluconazole therapy in patients with severe fungal infections, EUR J CL M, 18(3), 1999, pp. 165-174
Authors:
Kullberg, BJ
de Pauw, BE
Citation: Bj. Kullberg et Be. De Pauw, Therapy of invasive fungal infections, NETH J MED, 55(3), 1999, pp. 118-127
Authors:
Verweij, PE
van den Berth, MFQ
Rath, PM
de Pauw, BE
Voss, A
Meis, JFGM
Citation: Pe. Verweij et al., Invasive aspergillosis caused by Aspergillus ustus: Case report and review, J CLIN MICR, 37(5), 1999, pp. 1606-1609
Authors:
de Pauw, BE
Meunier, F
Citation: Be. De Pauw et F. Meunier, The challenge of invasive fungal infection, CHEMOTHERA, 45, 1999, pp. 1-14
Risultati:
1-7
|